跳至主要内容
临床试验/NL-OMON49016
NL-OMON49016招募中不适用

Assessing the role of local inflammatory, fibroproliferative, and osteogenic biomarkers in Systemic Sclerosis related Interstitial Lung Disease. - ILD-SSc study

niversitair Medisch Centrum Groningen0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Age 18-70 years
  • Written informed consent
  • Formal diagnosis of Systemic Sclerosis based on ACR/EULAR criteria
  • Formal diagnosis of interstitial lung disease (for 15 of 20 included

排除标准

  • Patients who are mentally incompetent
  • Vascular event or chemotherapy in the preceding 3 months
  • Inflammation of unknown origin
  • Other lung disease present
  • Use of anti-inflammatory medication or antibiotics

研究者

相似试验